Pre-Treatment workouts may boost strength in head and neck cancer patients
NCT ID NCT05418842
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether a short exercise program before chemoradiotherapy helps head and neck cancer patients maintain physical function. 47 adults with head and neck cancer were randomly assigned to either an exercise prehabilitation group or usual care. The exercise program lasted at least 2 weeks, and researchers measured walking ability, muscle strength, and quality of life before and after treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
47 people
The number who actually took part.
- Started
-
May 2021
- Finished
-
Jun 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age ≥18 years old; * Histologically confirmed HNSCC located on the oral cavity, larynx, oropharynx, hypopharynx, nasopharynx or in lymph nodes from an unknown primary tumor (stage I-IV); * Proposed for concomitant chemoradiotherapy with curative intent; * Date of treatment beginning ≥2 weeks from baseline assessment; * ECOG-Performance Status 0-1. Exclusion Criteria: * Completion of previous anticancer treatment within less than a year; * Uncontrolled hypertension, cardiac or pulmonary disease; * Contraindications to exercise training; * Inability to provide informed consent; * Expected inability to fulfil the proposed schedule.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Head and neck neoplasms are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centro Hospitalar Vila Nova de Gaia/Espinho
Vila Nova de Gaia, Porto District, 4434-502, Portugal
-
Instituto Português de Oncologia do Porto (IPO-Porto)
Porto, Região, Portugal
-
Liga Portuguesa Contra o Cancro - Núcleo Regional do Norte (LPCC-NRN)
Porto, Portugal
-
University of Aveiro
Aveiro, 3810-193, Portugal
-
University of Maia
Maia, Porto District, 4475-690, Portugal
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New PET tracer aims to light up hidden cancer targets
- Can immunotherapy before surgery stop early oral cancer from returning?
- Can a glowing dye show surgeons where head and neck tumors end?
- Shorter radiation course tested for advanced head and neck cancer
- When cancer blocks the airway, doctors lack a playbook. experts aim to write one.
- AI reads tumor slides to match cancer patients with trials